These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 9515547
1. Limited value of scintimammography and contrast-enhanced MRI in the evaluation of microcalcification detected by mammography. Tiling R, Khalkhali I, Sommer H, Linke R, Moser R, Willemsen F, Pfluger T, Tatsch K, Hahn K. Nucl Med Commun; 1998 Jan; 19(1):55-62. PubMed ID: 9515547 [Abstract] [Full Text] [Related]
2. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI. Sommer H, Tiling R, Pechmann M, Kindermann G, Kress K, Moser R, Tatsch K, Hahn K, Pfluger T, Assemi C. Zentralbl Gynakol; 1997 Jan; 119(1):6-11. PubMed ID: 9050197 [Abstract] [Full Text] [Related]
3. Role of technetium-99m sestamibi scintimammography and contrast-enhanced magnetic resonance imaging for the evaluation of indeterminate mammograms. Tiling R, Khalkhali I, Sommer H, Moser R, Meyer G, Willemsen F, Pfluger T, Tatsch K, Hahn K. Eur J Nucl Med; 1997 Oct; 24(10):1221-9. PubMed ID: 9323262 [Abstract] [Full Text] [Related]
4. Technetium-99m sestamibi in the diagnosis of breast cancer. The Mayagüez Medical Center experience. Farías-Jimenez J, Rivera A, Carlo VM. Bol Asoc Med P R; 2001 Oct; 93(1-12):9-11. PubMed ID: 12755069 [Abstract] [Full Text] [Related]
5. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions. Lind P, Gallowitsch HJ, Kogler D, Kresnik E, Mikosch P, Gomez I. Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502 [Abstract] [Full Text] [Related]
6. Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma. Khalkhali I, Cutrone JA, Mena IG, Diggles LE, Venegas RJ, Vargas HI, Jackson BL, Khalkhali S, Moss JF, Klein SR. Radiology; 1995 Aug; 196(2):421-6. PubMed ID: 7617855 [Abstract] [Full Text] [Related]
7. Can scintimammography with (99m)Tc-MIBI identify multifocal and multicentric primary breast cancer? Cwikla JB, Buscombe JR, Holloway B, Parbhoo SP, Davidson T, McDermott N, Hilson AJ. Nucl Med Commun; 2001 Dec; 22(12):1287-93. PubMed ID: 11711898 [Abstract] [Full Text] [Related]
8. Technetium-99m sestamibi scintimammography: the influence of histopathological characteristics, lesion size and the presence of carcinoma in situ in the detection of breast carcinoma. Howarth D, Sillar R, Clark D, Lan L. Eur J Nucl Med; 1999 Nov; 26(11):1475-81. PubMed ID: 10552090 [Abstract] [Full Text] [Related]
9. Diagnostic value of 99mTc MIBI scintimammography in patients with breast lesions. Yildiz A, Colak T, Güngör F, Ozuğur S, Boz A, Tunçdemir F, Akaydin M. Rev Esp Med Nucl; 2001 Jun; 20(4):276-81. PubMed ID: 11440709 [Abstract] [Full Text] [Related]
10. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography. Gommans GM, van der Zant FM, van Dongen A, Boer RO, Teule GJ, de Waard JW. Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524 [Abstract] [Full Text] [Related]
11. Scintimammographic findings of in situ ductal breast carcinoma in a double-phase study with Tc-99m(V) DMSA and Tc-99m MIBI value of Tc-99m(V) DMSA. Papantoniou V, Sotiropoulou M, Stipsaneli E, Louvrou A, Feda H, Christodoulidou J, Pampouras G, Zerva C, Keramopoulos A, Michalas S. Clin Nucl Med; 2000 Jun; 25(6):434-9. PubMed ID: 10836691 [Abstract] [Full Text] [Related]
12. Clinical experience with 99mTc-MIBI scintimammography in patients with breast microcalcifications. Fondrinier E, Muratet JP, Anglade E, Fauvet R, Berger V, Lorimier G, Jallet P. Breast; 2004 Aug; 13(4):316-20. PubMed ID: 15325666 [Abstract] [Full Text] [Related]
13. The role of scintimammography with 99mTc-sestamibi as a complementary diagnostic technique in the detection of breast cancer. Danielsson R, Reihnér E, Grabowska A, Boné B. Acta Radiol; 2000 Sep; 41(5):441-5. PubMed ID: 11016763 [Abstract] [Full Text] [Related]
14. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS. Kim JS, Lee SM, Cha ES. Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881 [Abstract] [Full Text] [Related]
15. Scintimammography with Tc-99m sestamibi. Khalkhali I, Iraniha S, Cutrone JA, Diggles LE, Klein SR. Acta Med Austriaca; 1997 Jul; 24(2):46-9. PubMed ID: 9227786 [Abstract] [Full Text] [Related]
16. [A Spanish multicenter scintigraphic study of the breast using Tc 99m MIBI. Report of results]. Prats E, Carril J, Herranz R, Meroño E, Banzo J, Gtemegmmt YE. Rev Esp Med Nucl; 1998 Jul; 17(5):338-50. PubMed ID: 9812008 [Abstract] [Full Text] [Related]
17. Comparison of technetium-99m-sestamibi scintimammography with contrast-enhanced MRI for diagnosis of breast lesions. Tiling R, Sommer H, Pechmann M, Moser R, Kress K, Pfluger T, Tatsch K, Hahn K. J Nucl Med; 1997 Jan; 38(1):58-62. PubMed ID: 8998151 [Abstract] [Full Text] [Related]
19. [99m Tc-MIBI scintigraphy compared to mammography in the diagnosis of breast cancer in dense, operated and young women breasts]. Mulero F, Nicolás F, Castellón MI, Fuentes T, de la Cruz P, Roca V, Abad L, Nuño de La Rosa JA. Rev Esp Med Nucl; 2000 Sep; 19(5):344-9. PubMed ID: 11062110 [Abstract] [Full Text] [Related]
20. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women. Sun SS, Hsieh JF, Tsai SC, Ho YJ, Lee JK, Kao CH. Anticancer Res; 2000 Sep; 20(3B):2133-6. PubMed ID: 10928166 [Abstract] [Full Text] [Related] Page: [Next] [New Search]